Here, we established a functional <i>in vitro</i> model, to study the differential responses of asthma patients to omalizumab (an IgE targeting biological) therapy.<h4>Methods</h4>White blood cells isolated from asthmatic children and adolescents were pre-treated with omalizumab. Here, IGHE is linked to asthma.